Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Neuropeptides ; 76: 101937, 2019 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-31253440

RESUMO

The progesterone metabolite, allopregnanolone (AlloP), is a GABAA receptor modulating steroid and is known to have orexigenic and pro-obesity effects. The neurobiological mechanisms underpinning these effects are most likely due to enhanced GABAergic signaling in the lateral arcuate nucleus (ARC) and medial paraventricular nucleus (PVN) of the hypothalamus. Inspired by the finding that GABAergic signaling is also important for the orexigenic effects of the circulating hormone, ghrelin, we sought to determine the extent to which AlloP (one of the most potent endogenous GABAA-receptor modulators) operates alongside ghrelin to enhance food intake. Male rats with ad libitum access to standard chow were injected intravenously with AlloP and/or ghrelin, alone or in combination. The intake of the standard chow was greater after AlloP 1 mg/kg together with ghrelin 30 µg/kg than with 30 µg/kg ghrelin alone. Food intake was also increased for the combined treatment of AlloP 0.5 mg/kg + ghrelin 10 µg/kg, AlloP 1 mg/kg + ghrelin 10 µg/kg, and AlloP 0.5 mg/kg + ghrelin 30 µg/kg. There was no significant difference in food intake between the two ghrelin doses or between the two doses of AlloP and the vehicle. In electrophysiological studies, physiologically relevant concentrations of AlloP prolonged the current decay time of spontaneous inhibitory post-synaptic current of dissociated cells of the ARC and PVN. We conclude that AlloP enhances the hyperphagic effect of ghrelin, findings of potential relevance for the hyperphagia associated with the luteal phase of the reproductive cycle.


Assuntos
Núcleo Arqueado do Hipotálamo/efeitos dos fármacos , Ingestão de Alimentos/efeitos dos fármacos , Grelina/administração & dosagem , Núcleo Hipotalâmico Paraventricular/efeitos dos fármacos , Pregnanolona/administração & dosagem , Animais , Núcleo Arqueado do Hipotálamo/fisiologia , Grelina/fisiologia , Potenciais Pós-Sinápticos Inibidores/efeitos dos fármacos , Masculino , Núcleo Hipotalâmico Paraventricular/fisiologia , Pregnanolona/fisiologia , Ratos Wistar
2.
Biotechnol J ; 13(4): e1700691, 2018 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-29247601

RESUMO

This work is a proof of concept of how a sequence of industrial batch separation steps together are used to form an integrated autonomous downstream process. The sequence in this case study consisted of an anion chromatography step, virus inactivation and finally a hydrophobic chromatography step. Moving from batch to integrated separation minimizes hold-up times, storage tanks, and required equipment. The conversion from batch to integrated mode is achieved by extracting operating points and separation data from batch chromatograms. The integrated separation process is realized on an ÄKTA Pure controlled by an open research software called Orbit, making it possible to operate complex process configurations including multiple steps. The results from this case study is the principle and method of the steps taken to automation, achieving a more continuous and efficient downstream process.


Assuntos
Cromatografia de Afinidade/métodos , Cromatografia por Troca Iônica/métodos , Automação Laboratorial , Indústrias , Inativação de Vírus
3.
Neuropsychobiology ; 68(1): 15-23, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-23774881

RESUMO

BACKGROUND/AIMS: Allopregnanolone or 3α-hydroxy-5α-pregnan-20-one (AlloP) is normally sedative and anxiolytic, but can under provoking circumstances paradoxically induce aggressive behavior. Therefore, it is of particular interest to determine if there is a relationship between an anxiolytic effect and aggressive behavior following AlloP administration. METHOD: Male Wistar rats were housed in triads comprising of 1 young rat (35 days) and 2 older rats (55 days), with the intent of producing a social hierarchy. The triads were sampled for total serum testosterone and submitted to a social challenge in the form of a food competition test (FCT), where the rats competed for access to drinking sweetened milk. At baseline, the younger rats were identified as subordinates. To test for the behavioral effect of AlloP, the subordinate rats were given intravenous AlloP injections of 0.5 and 1 mg/kg. To assess the optimal AlloP effect, 6 intervals (5, 10, 15, 20, 30 and 40 min) between injection and the FCT were used. In separate studies, AlloP was also given by subcutaneous and intraperitoneal administration at 10 and 17 mg/kg. RESULTS: AlloP (1 mg/kg, i.v.) increased drinking time and aggressive behavior in subordinate rats, with a positive correlation between these behaviors. The subcutaneous injection (17 mg/kg) also increased drinking time in subordinate animals. Serum testosterone concentration was higher in dominant compared to subordinate rats, and correlated with drinking time and weight. CONCLUSIONS: AlloP increased drinking time and aggressive behavior, and the correlation indicates a relationship between an anxiolytic effect and aggressive behavior.


Assuntos
Agressão/efeitos dos fármacos , Ansiolíticos/farmacologia , Comportamento Competitivo/efeitos dos fármacos , Comportamento Alimentar/efeitos dos fármacos , Hierarquia Social , Pregnanolona/farmacologia , Esteroides/farmacologia , Administração Intravenosa , Animais , Ansiolíticos/administração & dosagem , Peso Corporal/efeitos dos fármacos , Relação Dose-Resposta a Droga , Injeções Intraperitoneais , Injeções Subcutâneas , Masculino , Pregnanolona/administração & dosagem , Ratos , Ratos Wistar , Esteroides/administração & dosagem , Testosterona/sangue , Fatores de Tempo
4.
Gen Comp Endocrinol ; 177(1): 62-9, 2012 May 15.
Artigo em Inglês | MEDLINE | ID: mdl-22387985

RESUMO

Chronic stress and its concomitant neurobiological consequences are, in all probability, provocateurs of mental disease in humans. To gain some insight into the provocative effects of stress on hormonally dependent conditions, we developed a rat model that combines social subordinate housing (SSH) with withdrawal from combined progesterone (P) and estradiol (E) treatment (PEWD). At the start of the experiment, male Wistar rats were housed in triads consisting of one younger rat (35 days old) and two older rats (55 days old), with the intent of producing subordination stress in the younger animals. Triads containing three 35-day-old rats were used as age controls. Subordination stress was assessed with the elevated plus maze (EPM) and by corticosterone (CORT) analysis. Social rank within the triads was determined using a food competition test (FCT) and a tube test (TT). The younger rats (subordinate) and the dominant rats were assigned to 10 days of treatment with 5mg/kg P combined with 10 µg/kg E, or placebo (vehicle). Twenty-four hours after the last injection, the subordinate and dominant animals were tested in an open-field test (OFT) and a social challenge test (SCT). The SCT consisted of a 10-min exposure to three unfamiliar rats. SSH increased baseline CORT levels and reduced EPM open-arm time and post-EPM CORT levels compared to age-control rats. Only in the subordinate animals did PEWD increase locomotor activity and digging behavior, and reduce wrestling and pinning behavior. The behavioral results indicate an interaction between the effects of the lasting social subordinate stress and PEWD.


Assuntos
Estradiol/farmacologia , Progesterona/farmacologia , Animais , Corticosterona/sangue , Corticosterona/farmacologia , Masculino , Atividade Motora/efeitos dos fármacos , Pregnanolona/sangue , Pregnanolona/farmacologia , Ratos , Ratos Wistar , Estresse Fisiológico/fisiologia
5.
Physiol Behav ; 96(1): 91-7, 2009 Jan 08.
Artigo em Inglês | MEDLINE | ID: mdl-18793660

RESUMO

Withdrawal from progesterone and estradiol has been used as an animal model of premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD). In the clinical population individual sensitivity to sex steroid hormones, personality and heredity influence PMS/PMDD. Understanding the phenotypic risk factors of PMS/PMDD and drug development requires an animal model which incorporates individual steroid sensitivity. The main objective of this study was to investigate whether the individual trait of risk-taking and exploration influence the severity of PEWD in female rats. Thirty-two female Wistar rats in their diestrus phase were tested in the open field (OF) and divided into high responders (HR) and low responders (LR). Injections were given i.p. twice daily for 6 days, either 5 mg/kg progesterone combined with 10 microg/kg 17beta-estradiol, or vehicle (sesame oil). After a 24-hour withdrawal the animals were tested in the elevated plus maze (EPM). Blood samples for CORT analysis were collected after both behavioral tests. The HR rats withdrawn from progesterone and estradiol, spent less time on the EPM open arms and had lower CORT levels than the HR controls. The LR group showed no differences in EPM behavior and CORT levels during PEWD. The controls showed a stable trait of risk-taking and exploration, indicated by behavioral and CORT level correlations between the OF and EPM tests. These findings show that female rats with the trait of risk-taking and explorative behavior (HR) are more affected by PEWD.


Assuntos
Estradiol/efeitos adversos , Comportamento Exploratório/efeitos dos fármacos , Hormônios Esteroides Gonadais/efeitos adversos , Síndrome Pré-Menstrual/etiologia , Síndrome Pré-Menstrual/fisiopatologia , Progesterona/efeitos adversos , Corticosteroides/sangue , Análise de Variância , Animais , Modelos Animais de Doenças , Estradiol/administração & dosagem , Ciclo Estral/efeitos dos fármacos , Comportamento Exploratório/fisiologia , Feminino , Hormônios Esteroides Gonadais/administração & dosagem , Aprendizagem em Labirinto/efeitos dos fármacos , Progesterona/administração & dosagem , Ratos , Ratos Wistar , Assunção de Riscos
6.
Horm Behav ; 50(2): 208-15, 2006 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-16677649

RESUMO

Allopregnanolone (3alpha-hydroxy-5alpha-pregnane-20-one) is a ring-A-reduced metabolite of progesterone, which is naturally produced during the luteal phase of the menstrual cycle, during pregnancy and by stressful events. The steroid hormone inhibits neural functions through increased chloride ion flux through the GABA(A) receptor. The effects and subsequent withdrawal symptoms are similar to those caused by alcohol, benzodiazepines and barbiturates. This study examined the withdrawal effects of progesterone with regards to the influence of individual baseline exploration and risk taking. Rats were tested on the elevated plus maze (EPM) before hormonal treatment, in order to evaluate differences in risk taking and exploration of open and elevated areas. Treatment consisted of ten consecutive once a day progesterone or vehicle s.c. injections. On the last day of treatment, estradiol was injected in addition to progesterone, followed by a 24-h withdrawal before testing in the open field test (OF). Progesterone-treated rats showed a withdrawal effect of open area avoidance in the OF. The vehicle-treated control rats showed strong correlations between the EPM and OF parameters. This relationship was not found for the progesterone group at withdrawal. Rats with greater numbers of open arm entrance in the EPM pretest showed an increased sensitivity to progesterone withdrawal (PWD) compared to rats with low exploration and risk taking. The results indicate that the effects of PWD relate to individual exploration and risk taking. Furthermore, the possible analogy of PWD and PMS/PMDD in relation to individual traits is discussed.


Assuntos
Ansiedade/psicologia , Comportamento Animal/fisiologia , Progesterona/efeitos adversos , Síndrome de Abstinência a Substâncias/psicologia , Animais , Comportamento Animal/efeitos dos fármacos , Comportamento Exploratório/fisiologia , Masculino , Atividade Motora/fisiologia , Ratos , Ratos Wistar , Receptores de GABA-A/efeitos dos fármacos , Assunção de Riscos
7.
Brain Res Rev ; 51(2): 212-39, 2006 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-16368148

RESUMO

This article will review neuroactive steroid effects on serotonin and GABA systems, along with the subsequent effects on cognitive functions. Neurosteroids (such as estrogen, progesterone, and allopregnanolone) are synthesized in the central and peripheral nervous system, in addition to other tissues. They are involved in the regulation of mood and memory, in premenstrual syndrome, and mood changes related to hormone replacement therapy, as well as postnatal and major depression, anxiety disorders, and Alzheimer's disease. Estrogen and progesterone have their respective hormone receptors, whereas allopregnanolone acts via the GABA(A) receptor. The action of estrogen and progesterone can be direct genomic, indirect genomic, or non-genomic, also influencing several neurotransmitter systems, such as the serotonin and GABA systems. Estrogen alone, or in combination with antidepressant drugs affecting the serotonin system, has been related to improved mood and well being. In contrast, progesterone can have negative effects on mood and memory. Estrogen alone, or in combination with progesterone, affects the brain serotonin system differently in different parts of the brain, which can at least partly explain the opposite effects on mood of those hormones. Many of the progesterone effects in the brain are mediated by its metabolite allopregnanolone. Allopregnanolone, by changing GABA(A) receptor expression or sensitivity, is involved in premenstrual mood changes; and it also induces cognitive deficits, such as spatial-learning impairment. We have shown that the 3beta-hydroxypregnane steroid UC1011 can inhibit allopregnanolone-induced learning impairment and chloride uptake potentiation in vitro and in vivo. It would be important to find a substance that antagonizes allopregnanolone-induced adverse effects.


Assuntos
Encéfalo/metabolismo , Transtornos Cognitivos/metabolismo , Cognição , Hormônios Esteroides Gonadais/metabolismo , Serotonina/metabolismo , Ácido gama-Aminobutírico/metabolismo , Animais , Encéfalo/efeitos dos fármacos , Encéfalo/fisiopatologia , Cognição/efeitos dos fármacos , Transtornos Cognitivos/induzido quimicamente , Transtornos Cognitivos/fisiopatologia , Hormônios Esteroides Gonadais/efeitos adversos , Humanos , Aprendizagem/efeitos dos fármacos , Vias Neurais/efeitos dos fármacos , Vias Neurais/metabolismo , Vias Neurais/fisiopatologia , Receptores de GABA-A/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...